U.S. demand for enzymes will increase 6.7% annually to $1.6 billion in 2006, according to Enzymes, a report by The Freedonia Group, Cleveland, OH.
This growth will be fueled by the commercialization of novel, high-value enzymes designed for specific applications such as biocatalysts, pharmaceuticals and other fast growth markets. According to the study, pharmaceuticals will continue to lead the enzyme market, with growth expected to advance 9.6% a year. Rapid gains will also be recorded in biocatalyst applications, according to the study.
Freedonia Group Predicts Enzyme Demand Will Increase
Published November 11, 2005
blog comments powered by Disqus